The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label, phase II study of ladiratuzumab vedotin (LV) for advanced gastric and gastroesophageal junction adenocarcinoma (SGNLVA-005, Trial-in-Progress).
 
Amna Falak Sher
Research Funding - Seagen (Inst)
 
Justine Yang Bruce
Leadership - ImageMoverMD (I)
Stock and Other Ownership Interests - ImageMoverMD (I)
Consulting or Advisory Role - Genzyme
Research Funding - Kura Oncology (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Sensei Biotherapeutics (Inst)
 
Sung Yong Oh
No Relationships to Disclose
 
Ian Churchill Anderson
Research Funding - multiple, including Merck, Astra Zenica, Seattle Genetics, etc
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; AstraZeneca; Bayer; Celgene; Genentech/Roche; Halozyme; Merck Serono; Novartis; Taiho Pharmaceutical; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; Lilly; Novartis
 
Louise M. Nott
Honoraria - Merck Serono
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Novartis; Novartis; Roche
 
Jong-Seok Lee
Consulting or Advisory Role - AstraZeneca; Ono Pharmaceutical
 
Chia-Chi Lin
Honoraria - Daiichi Sankyo; Lilly; Novartis; Novartis; Roche
Consulting or Advisory Role - Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Travel, Accommodations, Expenses - BeiGene; Daiichi Sankyo; Daiichi Sankyo; Lilly; Novartis
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Genentech
Research Funding - AstraZeneca; Merck
 
Byoung Yong Shim
No Relationships to Disclose
 
Wu-Chou Su
No Relationships to Disclose
 
Troy H. Guthrie
No Relationships to Disclose
 
Nashat Y. Gabrail
Consulting or Advisory Role - Celgene; Chemiocare
Speakers' Bureau - Janssen Oncology; Janssen Oncology; Janssen Oncology; Karyopharm Therapeutics; Taiho Pharmaceutical; Taiho Pharmaceutical; Tesaro/GSK
Research Funding - Amgen (Inst); Bayer (Inst); Chemiocare (Inst); Chemiocare (Inst); Kartos Therapeutics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Oncology Supply
 
Rachel E. Sanborn
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - Abbvie; Amgen; ARIAD; AstraZeneca; Celldex; Genentech/Roche; Peregrine Pharmaceuticals; Seagen; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - AstraZeneca; Five Prime Therapeutics; Janssen Oncology
 
Arielle Shebay Lee
No Relationships to Disclose
 
Diego Luigi Cortinovis
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche/Genentech
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Paul Swiecicki
Consulting or Advisory Role - Regeneron
Research Funding - Ascentage Pharma Group; Pfizer
 
Yinghui Wang
Employment - Seagen
Stock and Other Ownership Interests - Seagen
Travel, Accommodations, Expenses - Seagen
 
Zejing Wang
Employment - Seagen
Stock and Other Ownership Interests - Seagen
Travel, Accommodations, Expenses - Seagen
 
Jae Yong Cho
No Relationships to Disclose